This approach allowed us to capture a wide range of studies, from early foundational work to recent clinical trials, providing a balanced overview of the field
Pregnant or breastfeeding individuals should avoid most research peptides
doi: 10.1038/s41579-019-0256-8 79 KruglikovI
Fujita H, Taniai H, Murayama H, Ohshiro H, Hayashi H, Sato S, Kikuchi N, Komatsu T, Komatsu K, Komatsu K, Narita T, Yamada Y (2014) DPP-4 inhibition with alogliptin on top of angiotensin II type 1 receptor blockade ameliorates albuminuria via up-regulation of SDF-1 in type 2 diabetic patients with incipient nephropathy
Jiang WD, Liu Y, Hu K, Jiang J, Li SH, Feng L, Zhou XQ